logologo
QuantliQuantli

SEC Filings

/

Microchip Technology (MCHP) FY2025: Revenue Down 42%, Restructuring Underway Amid Inventory Correction

SEC Filing

10-K

Microchip Technology (MCHP) FY2025: Revenue Down 42%, Restructuring Underway Amid Inventory Correction

Suhaib

Executive Summary

Microchip reported fiscal 2025 revenue of $4.4 billion, down 42% year-over-year, as customers worked through excess inventory built during prior supply constraints. The company swung to a net loss, closed one fab facility, and implemented a 10% headcount reduction to align costs with the weaker demand environment.

What happened

Microchip's fiscal 2025 results reflect a severe inventory correction following the post-pandemic boom. Net sales fell 42.3% to $4.4 billion as customers with bloated inventories from prior supply shortages pushed out or canceled orders. The mixed-signal microcontroller segment, the company's largest line at 51% of sales, declined 47%, while analog products fell 43%. Gross margin contracted from 65.4% to 56.1%, reflecting not just lower volumes but $173 million in unabsorbed capacity charges from running factories well below normal utilization, compared to only $41 million in the prior year. Operating margin collapsed from 33.7% to 6.7%. The company recorded a small net loss of $0.5 million versus net income of $1.9 billion in fiscal 2024. Despite production cuts, inventory remained stubbornly high at $1.29 billion, representing 251 days of supply versus 224 days a year earlier. Operating cash flow fell 69% to $898 million. In response, management announced the closure of Fab 2 in Tempe (completed May 2025), expected to generate $90 million in annual cash savings, and a 10% workforce reduction targeting an additional $90-100 million in annual operating expense savings. The company also paused most factory expansion activity and reduced planned capital spending to below $100 million for fiscal 2026, down from $126 million in fiscal 2025 and $285 million in fiscal 2024.

Why it matters for investors

The magnitude of the revenue decline and margin compression signals more than cyclical weakness—it reflects structural destocking after customers over-ordered during supply shortages. The shift from 6.7% operating margin in fiscal 2025 versus 33.7% in fiscal 2024 illustrates the high fixed-cost nature of semiconductor manufacturing. When revenue falls sharply, unabsorbed factory costs become a material drag. Microchip's response—closing a fab, cutting headcount, and slashing capex—indicates management believes current demand reflects a new baseline requiring a smaller operating footprint. The continued elevation in inventory days (251 versus 224) despite lower production suggests the destocking cycle has further to run. This dynamic is compounded by rising uncertainty around tariffs. New U.S. tariffs imposed in March and April 2025 on China and other countries, along with retaliatory measures, create both cost pressures and demand risks, particularly in China, which represented 17% of sales. The company's ability to return to profitability depends on whether customers have fully normalized inventory levels and whether tariff uncertainty stabilizes. The closure of Fab 2 and the workforce reduction are pre-emptive actions to protect margins, but the benefits won't materialize until inventory clears on a first-in, first-out basis. The $1.45 billion raised through preferred stock issuance provides liquidity cushion as the company manages through the downturn, but also introduces fixed dividend obligations. With $5.66 billion in debt and only $772 million in cash, the balance sheet is leveraged heading into a period of earnings pressure.

Bullish points

  • Operating cash flow remained positive at $898 million despite the revenue decline, indicating the business can still generate cash even in a severe downturn, though down significantly from $2.89 billion in the prior year.

  • The company raised $1.45 billion through Series A Preferred Stock issuance, bolstering liquidity and providing financial flexibility to weather the inventory correction cycle without breaching debt covenants.

  • Management took decisive cost actions—closing Fab 2 and reducing headcount by 10%—which are expected to reduce annual costs by $115-125 million, positioning the company for improved profitability when demand stabilizes.

  • Gross margin of 56.1%, while compressed, still reflects a structurally profitable business with proprietary products; management attributes much of the margin decline to temporary unabsorbed capacity charges rather than permanent pricing erosion.

Bearish points

  • Revenue collapsed 42.3% year-over-year with the company swinging from $1.9 billion in net income to a net loss, indicating severe demand destruction that may take multiple quarters to reverse.

  • Inventory days increased to 251 from 224 despite production cuts, suggesting the destocking cycle is not yet complete and that further revenue pressure or write-downs may occur.

  • Unabsorbed capacity charges surged to $173 million from $41 million, directly indicating factories running far below optimal levels and reflecting ongoing operational inefficiency until demand recovers.

  • The company faces material tax disputes with the IRS, Malaysian authorities (potential liability up to $410 million), and German tax authorities (potential liability up to $92 million), creating uncertainty around future cash tax obligations.

  • New U.S. tariffs imposed in March and April 2025 on China and other countries, combined with retaliatory measures, introduce significant uncertainty around both input costs and customer demand, particularly in China which represents 17% of sales.

Key highlights

Microchip is navigating a severe inventory correction following the post-pandemic semiconductor boom. The company's fiscal 2025 revenue fell 42% to $4.4 billion, driven by customers reducing bloated inventories accumulated during prior supply shortages. Gross margin compressed from 65.4% to 56.1%, with $173 million in unabsorbed capacity charges reflecting factories running well below normal utilization. The company swung from $1.9 billion in net income to a small net loss. Despite cutting production, inventory remained elevated at 251 days of supply. Management responded by closing the Tempe fab (Fab 2), cutting headcount by 10%, and slashing capital spending to below $100 million for fiscal 2026—collectively targeting over $115 million in annual savings. Operating cash flow fell 69% to $898 million, but the company raised $1.45 billion through preferred stock to maintain liquidity. With $5.66 billion in debt and ongoing tax disputes (including potential liabilities of $410 million in Malaysia and $92 million in Germany), Microchip is restructuring to protect margins while waiting for customer inventories to normalize. New tariffs imposed in March and April 2025 add further uncertainty to the demand outlook.

Management commentary

Management attributed the fiscal 2025 revenue decline to adverse economic conditions, including slowing economic activity, increasing business uncertainty, persistent inflation, high interest rates, and shorter product lead times, which resulted in customers holding higher inventory levels and delaying or reducing orders. The company stated it 'began to see evidence of improvements in our business in the March 2024 quarter which have continued in fiscal 2025, such as a decrease in customer requests to push out or cancel backlog while the number of expedites and shipment pull in requests grew,' but acknowledged 'the overall macroeconomic environment remained weak throughout fiscal 2025 as we navigated through a large inventory correction.' Regarding restructuring actions, management announced on December 2, 2024 its 'decision to close our Tempe, Arizona wafer fabrication facility that we refer to as Fab 2,' which was completed in May 2025 and is expected to 'generate annual cash savings of approximately $90 million.' On March 3, 2025, the company announced 'additional restructuring actions to reduce costs, resize manufacturing operations and to reduce headcount' including 'a 10% headcount reduction across our company to decrease our operating expenses,' which is expected to 'reduce our ongoing operating expenses by approximately $90 million to $100 million on an annualized basis.' Management noted 'consistent with the macroeconomic environment, most of our factory expansion activity remains paused, we have reduced our planned capital investments, and we remain focused on reducing our inventory levels and days of inventory through fiscal 2026.' Regarding tariff uncertainty, management stated 'in March and April 2025, the U.S. imposed tariffs on imports from China and other countries and foreign governments imposed additional tariffs on imports from the U.S. It is unclear what tariffs will apply to semiconductors during this time of change.'

What to watch next

Investors should monitor:

  • Whether inventory days decline in fiscal 2026, signaling customers have completed destocking and are returning to normal ordering patterns, which would support a revenue recovery.

  • The actual realization of the $115-125 million in targeted annual cost savings from the Fab 2 closure and headcount reduction, and the timeline for these savings to flow through to operating margins.

  • Resolution or further developments in the tax disputes with the IRS, Malaysian authorities (potential $410 million liability), and German authorities (potential $92 million liability), which could materially impact cash flows.

  • The ultimate impact of the March and April 2025 tariffs on semiconductors, including whether exemptions are granted and whether customer demand in China and other affected markets stabilizes or deteriorates further.

This summary is based solely on excerpts from the company's Form 10-K filing.

Comments (0)

MCHP

Microchip Technology Inc

NASDAQ

Information Technology

$80.96

USD

-$0.72

(-0.88%)

At close: Jul 17, 2026, 4:00 PM EDT

Market Cap:

$43.56B

Volume:

12.4M

52w High:

$105.91

P/E Ratio (TTM):

189.39

View Company Page

Daily Analyst Ratings

Track how 1,000 Wall Street analysts rate stocks — updated daily.

See which S&P 500 stocks analysts expect to rise most.

View Top Upside Stocks

Top Gainers

CDNA

CareDx Inc

$40.34

+35.6%

ATAI

AtaiBeckley Inc

$7.15

+33.4%

MAN

ManpowerGroup Inc

$51.65

+32.4%

MAAS

Maase Inc

$20.95

+26.4%

View all

Upcoming IPOs